Open AccessType and screen policy in the blood bank: Is AHG cross-match still required? A study at a multispecialty corporate hospital in India
Author(s) -
Sangeeta Pathak,
M Chandrashekhar,
GR Wankhede
Publication year - 2011
Publication title -
asian journal of transfusion science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.262
H-Index - 22
eISSN - 1998-3565
pISSN - 0973-6247
DOI - 10.4103/0973-6247.83242
Subject(s) - medicine , antibody , antigen , population , red cell , globulin , immunology , environmental health
Antibodies against only about 25-28 blood group antigens are known to cause hemolytic reactions (HTRs), and red cell antibody screening should detect such clinically significant antibodies. An extension of the antibody screening test is the 'type and screen' done to detect clinically significant antibodies, omiting the anti-human globulin (AHG) cross-match.